3rd Quarter - Report

THE CONAFAY GROUP, LLC for MICROBIOME THERAPEUTICS INNOVATION GROUP (MTIG)

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Seek approval for regulatory support; HR3437; Loans Act

Foreign entity interest: Microba Life Sciences; Servatus BioPharmaceuticals; Genetic Analysis

LobbyistCovered position, as disclosed
DARIN L GARDNER Legislative Correspondent Senator Tim Hutchinson; Research Assistant Senate HELP Committee; Chief of Staff Congresswoman Kay Granger
JOSH NARROW Intern Senator Casey

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3437 (117th)

Medical/Disease Research/Clinical Labs MED

eek approval for regulatory support; HR3437; Loans Act

Foreign entity interest: Microba Life Sciences; Servatus BioPharmaceuticals; Genetic Analysis

LobbyistCovered position, as disclosed
DARIN L GARDNER Legislative Correspondent Senator Tim Hutchinson; Research Assistant Senate HELP Committee; Chief of Staff Congresswoman Kay Granger
JOSH NARROW Intern Senator Casey

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3437 (117th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
GENETIC ANALYSIS Norway Norway — —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.